The Latest Technology Treatment Of Cancer

1. The Latest Technology Treatment OfCancer Dr.WongWengSengasOncologistsandSpecialistConsultantsfromtheCancerCentre,SMG explained that everyone has cancercells in his body. Cancer cells can be distinguished from normal cells based on a number of morphological characteristics, behavior, andgenetic. Cancer cells have development of abnormal, it can spread and invade normal cells other right 'terrorists',andthesecellsdonothaveatimedeadlinelive. Ifaterroristcell hasalreadyspread to other organs, the eradication of the disease cancer thoroughly is very difficult toachieve. Cancertreatmentisgenerallydeterminedbasedonthestageofthecanceranditsspreadinthe body. Broadly speaking, there are four types of cancer treatment namely surgery, radiation therapy, chemotherapy and hormonetherapy. Chemotherapy is very commonly performed on cancer patients because this therapy is very effective in targeting cancer cells that havespread. However, chemotherapy can go kill normal cells healthy in addition to cancer cells, causing certain side effects, such as Alopecia, Neutropenia and in some rare cases,Cardiotoxicity. Regarding cancer treatment, Cancer Center, the one that offers the treatment current to the cancer. Treatment of cancer with increasing timegrowing.

2. If earlier treatment of cancers tend to hit the average for each patient without seeing more in detail the condition of the patient concerned, is now treatment for this serious disease has been morepersonal. The patient can put hope on the treatment of targeted therapy and immunotherapy which is minimal side effects and right ontarget. "The first cancer patients the average is given the same treatment of cancer, such as chemotherapy and not selective," said dr Wong Seng Weng, Medical Directory & Consultant Specialist Cancer Center (TCC), which is part of the Singapore Medical Group (SMG), in Jakarta, Saturday(24/1). Chemotherapy, he explained, clearing all the cells, both cancer and healthy. Side effects the most visible of the chemical therapy it is a disorder of appetite, hair loss, suppression of the immune system, to kidneydamage. Incontrastwithtargetedtherapy,thistherapyisonlyattackthecancercellsorcellsundergoing cleavage of the uncontrolled growth and spread can beinhibited. Before being given this therapy, the patient first must undergo examination of the genetic profile. "From here can be known a gene that is mutated so that it can be given theappropriate medication.Wecanalsoseewhatiscausingthecancercellscontinuetogrowandspread,then useddrugstoblockthesignalsinvolvedinthegrowthofcancercells,"saidmedicaloncologist. Genetictestingcanbedonebytakingasampleoftheresultswillbeabiopsyorabloodsample. Further, the drug targeted therapy works by utilizing the genemutation.

3. Thedruggetsintothebodyandfindcellswiththemutatedgenes,andthentakehimout.Arifin Ng, General Manager & Senior Vice President, SMG International Partners say, treatmentsof cancer compared to 10 years ago is already a lot of progress. "After targeted therapy, there is immunotherapy that is also minimal side effects," hesaid. In principle, he continued, immunotherapy works by activating the immune system (immune) patients. Immunotherapy works by preventing the interaction between T cells belonging to the immune system and thetumor. WhenthetumorandTcellsinteract, aproteininthetumorwhichis calledProgrammedDeath - Ligand 1 (PD-L1) knock out T cells so that immune cells can recognize and kill cancercells. "Thecombinationofimmunotherapywithchemotherapycanprovide80peraensuccessforthe treatmentof lung cancer," said dr.Wong. In Singapore, immunotherapy in addition to lung cancer, is also given for patients with skin cancer(melanoma). However, the Food and Drug Supervisory Agency of the United States the US FDA recently had also approved the granting of immunotherapy for other types ofcancer. By doing so, Singapore will implement immunotherapy for other cancers, such as head and neck cancer, kidney, stomach, lymph nodes/lymphoma (Hodgkins), and other cancers with specific genetic characteristics that are known to Mis-match repair (MMR) deficiency. The FDA in May 2007 has approved the use of immunotherapy for cancer with abnormal genes called the MMR deficiency. Cancer with a gene mutation that more will respond better toimmunotherapy. According to dr Wong, if the examination of the genetic profile suitable, the patient will be given targeted therapy. If it does not fit, immunotherapy be thesolution. SMG until now has 25 specialist doctors and 51 subspecialists with 35 clinics spread across Singapore. SMG started to expand abroad in 2015, one of which is Indonesia with Ciputra SMG Eye Clinic, and Vietnam. The cancer Centre is located in Paragon Medical & Mount Elizabeth Novena.